Australia seems poised to experience potentially transformative therapy for obesity: Retatrutide. This dual compound – working on both GLP-1 and GIP receptors – has remarkable results in international research, indicating considerable reductions in body fat. While regulatory clearance hasn't occurred with the Therapeutic Goods Administration (T… Read More